Wedbush maintains Intellia Therapeutics at neutral
Wedbush maintained its neutral rating on Intellia Therapeutics.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Wedbush maintained its neutral rating on Intellia Therapeutics.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.